Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Granulocyte Colony-stimulating Factor”

509 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 509 results

Testing effectiveness (Phase 2)Ended earlyNCT00969722
What this trial is testing

MAb-3F8 Plus Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus 13-cis-Retinoic Acid (RA) Plus GM-CSF in Primary Refractory Neuroblastoma Patients

Who this might be right for
Primary Refractory Neuroblastoma
United Therapeutics 1
Early research (Phase 1)Study completedNCT01435499
What this trial is testing

Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected Melanoma

Who this might be right for
Melanoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 21
Large-scale testing (Phase 3)Study completedNCT00769704
What this trial is testing

Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma

Who this might be right for
Melanoma
BioVex Limited 437
Testing effectiveness (Phase 2)Study completedNCT02044796
What this trial is testing

Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

Who this might be right for
Acute Biphenotypic Leukemiade Novo Myelodysplastic SyndromePreviously Treated Myelodysplastic Syndrome+3 more
Fred Hutchinson Cancer Center 199
Testing effectiveness (Phase 2)Ended earlyNCT00002778
What this trial is testing

Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 40
Testing effectiveness (Phase 2)Study completedNCT06117982
What this trial is testing

The Impact of Granulocyte Colony Stimulating Factor on Premature Ovarian Insufficiency

Who this might be right for
Primary Ovarian InsufficiencyPremature Ovarian Failure
Trio Fertility 11
Large-scale testing (Phase 3)Study completedNCT02642003
What this trial is testing

To Assess the Efficacy of Granulocyte Colony Stimulating Factor Versus Standard Medical Therapy in Patients of Decompensated Cirrhosis

Who this might be right for
Cirrhosis
Sir Ganga Ram Hospital 259
Large-scale testing (Phase 3)UnknownNCT03404752
What this trial is testing

Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients.

Who this might be right for
Breast Cancer
Gema Biotech S.A. 120
Early research (Phase 1)Study completedNCT02762799
What this trial is testing

Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics and Safety of Leucostim® Compared to Neupogen®

Who this might be right for
Leucocytosis
Biocad 60
Testing effectiveness (Phase 2)Study completedNCT00001750
What this trial is testing

Comparing Treatments for Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Heart, Lung, and Blood Institute (NHLBI) 32
Post-approval studies (Phase 4)Not Yet RecruitingNCT06047535
What this trial is testing

Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Combined With Isotretinoin for Maintenance Treatment of Patients With High-Risk Neuroblastoma in First Complete Response.

Who this might be right for
Neuroblastoma
SciClone Pharmaceuticals 62
Not applicableStudy completedNCT01362179
What this trial is testing

National Marrow Donor Program Long-Term Donor Follow-Up

Who this might be right for
Hematologic Neoplasms
Center for International Blood and Marrow Transplant Research 21,974
Testing effectiveness (Phase 2)Study completedNCT01202656
What this trial is testing

Effect of Colony Stimulating Factor on Implantation and Pregnancy Rates Following IVF (in Vitro Fertilization)

Who this might be right for
Infertility, Female
Center for Human Reproduction 129
Not applicableStudy completedNCT01459653
What this trial is testing

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

Who this might be right for
Febrile NeutropeniaCancerBreast Cancer+6 more
Sandoz 1,496
Post-approval studies (Phase 4)Not Yet RecruitingNCT06665737
What this trial is testing

Outcomes of Early and Late Administration G-CSF for Primary Prophylaxis in Non-Hodgkin's Lymphoma Patients

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)Granulocyte Colony Stimulating FactorFebrile Neutropenia (FN)+1 more
Department of Medical Services Ministry of Public Health of Thailand 126
Testing effectiveness (Phase 2)Study completedNCT00011934
What this trial is testing

Bone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid Leukemia

Who this might be right for
Leukemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Study completedNCT00001842
What this trial is testing

G-CSF for Granulocyte Donation

Who this might be right for
Healthy
National Institutes of Health Clinical Center (CC) 16
Not applicableStudy completedNCT00615901
What this trial is testing

Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 38
Testing effectiveness (Phase 2)Study completedNCT00031629
What this trial is testing

Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus

Who this might be right for
Recurrent Uterine Corpus SarcomaUterine Corpus Leiomyosarcoma
Gynecologic Oncology Group 51
Not applicableUnknownNCT01036932
What this trial is testing

Granulocyte Colony Stimulating Factor(G-CSF) Therapy for Patients With ACLF

Who this might be right for
Acute on Chronic Liver Failure
Govind Ballabh Pant Hospital 50
Load More Results